The Access to Medicines and Vaccines in Tunisia in a post-Covid-19 Era
C·A·Perspectives on Tunisia No. 04-2020 published
Najd Badri and Mehdi Bouhlel
The Access to Medicines and Vaccines in Tunisia in a post-Covid-19 Era
C·A·Perspectives on Tunisia No. 04-2020
30.12.2020 · C·A·P
Access to medicines and vaccines is a world-wide challenge especially in countries of the Global South such as Tunisia. Before and during the 2020 Covid-19 pandemic, the high demand for those products along with an international supply chain disruption made access to healthcare and especially essential medicines more complicated both globally and in Tunisia.
The C·A·Perspectives on Tunisia policy paper No. 04-2020 entitled "The Access to Medicines and Vaccines in Tunisia in a post-Covid-19 Era" by Najd Badri and Mehdi Bouhlel aims at tackling the medicine/ vaccine shortage in Tunisia in the post-Covid-19 era. The pros and cons of Tunisian public health politics and policies are highlighted, and the potential root causes that limit the accessibility of medicines and vaccines are analyzed. Finally, some recommendations for urgent reforms are given.
The policy paper is published in the Series C·A·Perspectives on Tunisia in the framework of the "Policy Advice and Strategy Development" Program in the framework of the Bavarian-Tunisian Action Plan 2016-2020 and supported by the Government of the Free State of Bavaria.
News zum Thema
C·A·Perspectives on Tunisia No. 05-2020 published
31.12.2020 · C·A·P
New Policy Paper in the Policy Advice and Strategy Development Programm
31.12.2020 · C·A·P
New Policy Paper in the Policy Advice and Strategy Development Programm
08.12.2020 · C·A·P
C·A·Perspectives on Tunisia No. 02-2020
26.08.2020 · C·A·P